Arkolith/Insider Trading/CDAK/Form 4

Williams Douglas E

See Remarks, DirectorCodiak BioSciences, Inc. (CDAK) · full profile →Form 4 · filed Jan 23, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2023Sell(S)5K$0.58$3K18K
Jan 19, 2023Option exercise(M)14K——23K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 19, 2023Option exercise(M)14K—$027K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-002399) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML